Loading…
Loading…
BIO · NYSE · Healthcare
“At a 9.5 P/E, this scientific tools maker proves that boring monopolies in lab equipment often hide behind unsexy names and patient capital requirements.”
— In the voice of Munger
Compute the compound annual growth rate for any investment period. The true annualized return that accounts for compounding.
Market Cap
$7.23B
P/E Ratio
9.51
Forward P/E
—
EPS
$27.87
PEG Ratio
-0.05
Book Value
$273.40
Dividend Yield
—
Profit Margin
29.42%
ROE
10.20%
Use the interactive cagr calculator with pre-loaded data for Bio-Rad Laboratories Inc - Class A. Adjust discount rates, growth assumptions, and projection horizons to model different scenarios.
Pre-loaded inputs for BIO: